A Close Look into China’s Contributions to the Health Silk Road
Belt & Road Series
Prof Yang Jian, Vice President and Senior Fellow in Shanghai Institute for International Studies (SIIS), gave an overview of the latest developments of the Health Silk Road (HSR) and China's work to bridge the global vaccine gap at the Chamber’s Belt and Road Working Group, hosted by Edmond Yue, Co-convenor, on 11 April. He said China had recently pledged to supply an additional 1 billion vaccines to Africa, on top of the 2 billion pledged globally in 2021, to help the continent achieve its goal of vaccinating 60% of the African population by 2022. The country was also working with the international community to promote mutual vaccine recognition.
Also speaking at the meeting, Henry Tillman, Founder of China Investment Research, gave members an in-depth analysis of China's mRNA vaccine development, saying there was hope that one or two mRNA vaccines would be released in late 2022. China was working closely with over 27 developing countries via technology transfer and joint ventures to help them set up factories to produce vaccines locally, among which Indonesia, Pakistan, UAE and Uzbekistan led in number of vaccines produced. He encouraged members to explore investment opportunities in medical infrastructure and pharmaceutical manufacturing along the HSR.
Page: 1 / 1